ArticlePDF Available

Curcumin Prevents High Fat Diet Induced Insulin Resistance and Obesity via Attenuating Lipogenesis in Liver and Inflammatory Pathway in Adipocytes


Abstract and Figures

Mechanisms underlying the attenuation of body weight gain and insulin resistance in response to high fat diet (HFD) by the curry compound curcumin need to be further explored. Although the attenuation of the inflammatory pathway is an accepted mechanism, a recent study suggested that curcumin stimulates Wnt signaling pathway and hence suppresses adipogenic differentiation. This is in contrast with the known repressive effect of curcumin on Wnt signaling in other cell lineages. We conducted the examination on low fat diet, or HFD fed C57BL/6J mice with or without curcumin intervention for 28 weeks. Curcumin significantly attenuated the effect of HFD on glucose disposal, body weight/fat gain, as well as the development of insulin resistance. No stimulatory effect on Wnt activation was observed in the mature fat tissue. In addition, curcumin did not stimulate Wnt signaling in vitro in primary rat adipocytes. Furthermore, curcumin inhibited lipogenic gene expression in the liver and blocked the effects of HFD on macrophage infiltration and the inflammatory pathway in the adipose tissue. We conclude that the beneficial effect of curcumin during HFD consumption is mediated by attenuating lipogenic gene expression in the liver and the inflammatory response in the adipose tissue, in the absence of stimulation of Wnt signaling in mature adipocytes.
Content may be subject to copyright.
Curcumin Prevents High Fat Diet Induced Insulin
Resistance and Obesity via Attenuating Lipogenesis in
Liver and Inflammatory Pathway in Adipocytes
Weijuan Shao
, Zhiwen Yu
, Yuting Chiang
, Yi Yang
, Tuanyao Chai
, Warren Foltz
, Huogen
, I. George Fantus
, Tianru Jin
1Division of Cell and Molecular Biology, Toronto General Research Institute, University Health Network, Toronto, Canada, 2Department of Nutrition, Public Health
Institute, Sun Yat-Sen University, Guangzhou, China, 3Department of Physiology, University of Toronto, Toronto, Canada, 4Radiation Medicine Program, The STTARR
Innovation Centre, Princess Margaret Hospital, University Health Network, Toronto, Canada, 5Banting and Best Diabetes Centre, Faculty of Medicine, University of
Toronto, Toronto, Canada
Mechanisms underlying the attenuation of body weight gain and insulin resistance in response to high fat diet
(HFD) by the curry compound curcumin need to be further explored. Although the attenuation of the inflammatory
pathway is an accepted mechanism, a recent study suggested that curcumin stimulates Wnt signaling pathway and hence
suppresses adipogenic differentiation. This is in contrast with the known repressive effect of curcumin on Wnt signaling in
other cell lineages.
Methodology and Principal Findings:
We conducted the examination on low fat diet, or HFD fed C57BL/6J mice with or
without curcumin intervention for 28 weeks. Curcumin significantly attenuated the effect of HFD on glucose disposal, body
weight/fat gain, as well as the development of insulin resistance. No stimulatory effect on Wnt activation was observed in
the mature fat tissue. In addition, curcumin did not stimulate Wnt signaling in vitro in primary rat adipocytes. Furthermore,
curcumin inhibited lipogenic gene expression in the liver and blocked the effects of HFD on macrophage infiltration and the
inflammatory pathway in the adipose tissue.
Conclusions and Significance:
We conclude that the beneficial effect of curcumin during HFD consumption is mediated by
attenuating lipogenic gene expression in the liver and the inflammatory response in the adipose tissue, in the absence of
stimulation of Wnt signaling in mature adipocytes.
Citation: Shao W, Yu Z, Chiang Y, Yang Y, Chai T, et al. (2012) Curcumin Prevents High Fat Diet Induced Insulin Resistance and Obesity via Attenuating
Lipogenesis in Liver and Inflammatory Pathway in Adipocytes. PLoS ONE 7(1): e28784. doi:10.1371/journal.pone.0028784
Editor: Regine Schneider-Stock, Erlangen University, Germany
Received July 8, 2011; Accepted November 15, 2011; Published January 9, 2012
Copyright: ß2012 Shao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: CIHR, Canadian Institutes of Health Research ( The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail:
.These authors contributed equally to this work.
¤ Current address: Ningxia Medical University, Yinchuan, People’s Republic of China
Type 2 diabetes mellitus (T2D) is increasing at an alarming rate
in both developed and developing countries, associated with a
combined health and economic burden worldwide [1]. The
epidemic of obesity and its related insulin resistance have
contributed significantly to the incidence of diabetes. It is now
generally accepted that both obesity and T2D are associated with
low grade chronic inflammation and that adipose tissue appears to
be the first organ that is affected [2]. The development of
inflammation and oxidative stress in adipose tissue leads to insulin
resistance [3,4]. Furthermore, accelerated hepatic lipogenic gene
expression and reduced liver fat export may also contribute to the
development of obesity [5,6].
Many naturally occurring dietary polyphenols possess antioxi-
dant and anti-inflammatory properties [7]. This could be achieved
by modulating an inflammatory or oxidative signaling pathway,
including NF-kB, Nrf2, and/or MAPK-dependent signaling
pathways [7,8,9]. Certain dietary polyphenols, such as curcumin,
also possess the anti-carcinogenic effects. One potential mecha-
nism of curcumin to repress tumorigenesis has been suggested to
be the inhibition of Wnt signaling, an essential pathway for
embryogenesis and cell proliferation [10,11].
Curcumin, a low-molecular-weight polyphenol derived from the
herbal remedy and dietary spice turmeric, was found to prevent obesity
and diabetes in mouse models [12]. Mechanistically, curcumin may
exert its beneficial effects via reducing insulin and leptin resistance,
attenuating inflammatory cytokine expression, accelerating fatty acid
oxidation, as well as increasing antioxidant enzyme expression [7]. In
addition, curcumin could also function as an inhibitor of p300 histone
acetyltransferase (HAT), a potential molecular mechanism for cancer
prevention and cardiovascular improvement [13,14].
PLoS ONE | 1 January 2012 | Volume 7 | Issue 1 | e28784
The Wnt/b-catenin (b-cat) signaling pathway was initially
discovered in colon cancer and in developmental studies of
Drosophila and frogs [15]. The role of the canonical Wnt signaling
pathway (defined as Wnt pathway hereafter) in metabolic
homeostasis has recently received increasing attention
[15,16,17]. Activation of Wnt pathway increases cellular and
nuclear b-cat level, which represses adipogenesis, while the
inhibition of Wnt signaling is required for PPARcinduction and
preadipocyte differentiation [18]. A very recent study showed that
curcumin stimulates Wnt/b-cat signaling in 3T3-L1 preadipocytes
and hence suppresses adipogenic differentiation [19]. Although
this finding provides a potential molecular mechanism for the
effect of curcumin in attenuating obesity, it is contradictory with
other reports in two ways. First, numerous studies have indicated
that curcumin exerts its anti-cancer effect via repressing Wnt
signaling [10,11]. Second, Wnt activation in mature adipocytes
was shown to induce insulin resistance [20], while curcumin is
known to attenuate insulin resistance [12].
In this study we have examined the effect of dietary curcumin in
a HFD mouse model in which the development of obesity and
insulin insensitivity was relatively slow due to the administration of
45% rather than 60% of calories from fat [8]. In this mouse model
as well as in primary rat adipocytes, we did not observe stimulation
of curcumin on Wnt pathway components or Wnt target gene
expression. However, curcumin attenuated lipogenic gene expres-
sion in hepatocytes, and blocked the effect of HFD on the
inflammatory response in the adipose tissue, associated with
decreased weight/fat gain, and the maintenance of normal glucose
tolerance and insulin sensitivity.
Materials and Methods
Curcumin was purchased from Sigma (St. Louis, MO).
Antibodies against PKB/Akt, phosphorylated PKB (Ser473),
phosphorylated b-cat (Ser675 b-cat), GSK-3b, phosphorylated
GSK-3a/b, and b-actin were obtained from Cell Signaling
Technology (Beverly, MA). Antibodies against NF-kB, total b-
cat, c-Myc, cyclin D1, phosphorylated JNK, SREBP1-c, F4/80
and HO-1 were from Santa Cruz Biotechnology (Santa Cruz,
CA). Thioredoxin-interacting protein (TxNIP) antibody was
obtained from MBL International Corporation (Woburn, MA).
ChREBP antibody was purchased from Novus Biologicals,
(Littleton, CO). Kits for glucose, cholesterol, free fatty acids
(FFA), and HDL assessment were from Abcam (Cambridge, MA).
Triglyceride (TG) assay kit was from Cayman Chemical (Ann
Arbor, Michigan). Leptin/insulin ELISA kit were from Crystal
Chem. Inc. (Downers Grove, IL). Adiponectin ELISA kit was from
R&D Systems (Minneapolis, MN). GSH/GSSG assay kit was from
Oxford Biomedical Research (Oxford, MI) and the method for
determining plasma GSH/GSSG ratio was described previously
Animal care and treatment
Male C57BL/6J mice from Jackson Laboratory (Bar Harbor,
Maine) were housed 5 per cage under the conditions of constant
temperature (22uC), a light/dark cycle of 12 h with free access to
food and water. Thirty-six five-week-old mice were randomly
divided into three groups. Group A were fed with the low-fat-diet
(LFD, control diet, 10% Kcal from fat), while group B with the
HFD (45% Kcal from soy bean fat). Group C were fed with HFD
with curcumin (4g/kg diet) added 2 days/week (Mondays and
Thursdays). Diets were prepared by Harlan Tekland (Madison,
WI) [8]. The animal experiments and protocols were approved by
the University Health Network Animal Care Committee and
performed in accordance with the guidelines of the Canadian
Council of Animal Care. The approval ID for this study is
MRI assessment of total fat mass and lipid content
MRI was performed using a 7 tesla Biospec 70/30 USR (Bruker
BioSpin MRI GmbH, Ettlingen, Germany) in The STTARR
Innovation Centre, Radiation Medicine Program, Princess
Margaret Hospital, University Health Network, Toronto, Canada,
as previously described [8].
Intraperitoneal (i.p.) glucose, insulin and pyruvate
tolerance tests
Mice were fasted overnight for glucose tolerance tests; or fasted
for 6 h for insulin and pyruvate tolerance tests. Following the
fasting, glucose (2 g/kg), insulin (0.65 U/kg) or pyruvate (2 g/kg)
was i.p. injected. Blood samples collected from tail vein were used
for glucose measurements.
Determination of blood biochemistry and liver TG
Ambient levels of plasma glucose, TG, total cholesterol, FFA
and HDL after an overnight fast were measured using kits
following the manufacturers’ instructions. Liver TG content was
determined as described [21].
Quantitative real-time RT-PCR
Real-time PCR was performed using iQ
Sybr Green (Bio-
Rad, Mississauga, On., Canada) using the Rotorgene according to
the protocols provided by the manufacturer. The relative mRNA
transcript levels were calculated according to the 2
Oligonucleotide primers for RT-PCR are summarized in Table 1.
Cell lines and primary cell cultures
HepG2 cells were purchased from ATCC (Manassas, VA).
They were cultured in a-MEM supplemented with 10% fetal
bovine serum (FBS). Epididymal fat pads from male wild-type
Wistar rats fed a normal diet were excised, minced in DMEM
containing 3% BSA and digested with 1 mg/ml collagenase Type
1 (Worthington Biochemical Corporation, Lakewood, NJ) at 37uC
for 60 min. The digested fat tissue was filtered through a mesh
(100 mm) and centrifuged at 500 rpm for 5 min to separate
floating adipocytes from the medium.After washing 4 times, cells
were maintained in DMEM containing 1% BSA at 37uC, with
additions as indicated.
Western blot analysis
Tissue samples were homogenized and equal amounts of
proteins (30 mg) were separated with denaturing SDS 10%
polyacrylamide gels. The method for Western blotting was as
previously described [8,22].
Luciferase (LUC) reporter analysis
The generation of ChREBP promoter constructs, as well as the
method for LUC reporter gene analysis was described previously
Immuno and Histological staining
The sections of epididymal adipose tissue were fixed in 10%
formalin, dehydrated, and embedded in paraffin. Adipose tissue
sections were stained with hematoxylin and eosin (H&E) to
examine the morphology and with the F4/80 antibody to detect
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 2 January 2012 | Volume 7 | Issue 1 | e28784
macrophages. Hepatic Oil O Red staining was conducted with the
routine method.
All results are expressed as mean 6SEM. Statistical significance
was assessed by ANOVA. Pvalue less than 0.05 was considered to
be statistically significant.
Long term dietary curcumin administration prevented
HFD-induced body-weight gain and obesity
In this chronic HFD mouse model, body-weight increased
significantly only after 16 weeks of HFD feeding (Fig. 1A). From
this time point to the end of the 28th week, dietary curcumin
significantly blocked the effect of HFD on body-weight gain
(Fig. 1A). HFD also significantly increased the weight of
epididymal fat pads, while curcumin supplementation significantly
blocked this stimulation (Fig. 1B). We then assessed total fat mass
of the animals by MRI and found stimulation by HFD and
inhibition by curcumin supplementation (Fig. 1C).
HFD feeding increased the fasting plasma insulin level
(0.2860.15 ng/ml for LFD, 0.6760.10 ng/ml for HFD,
p,0.05), while dietary curcumin resulted a reduction on its level
(0.1060.06 ng/ml in HFD plus curcumin, p,0.01 versus HFD).
Although HFD reduced and curcumin increased plasma adipo-
nectin level, the differences did not reach statistical significance
(7.2661.08 mg/ml for LFD, 5.9962.14 mg/ml for HFD, and
7.2261.09 mg/ml for HFD/curcumin).
Curcumin improved glucose disposal and insulin
To evaluate the functional outcome of long-term curcumin
supplementation on glucose homeostasis, we conducted an
intraperitoneal glucose tolerance test (IPGTT). A representative
IPGTT result performed at the end of the 20th week is presented
in Fig. 2A. Blood glucose levels were higher in the HFD animals
while curcumin significantly blocked these increase. To determine
whether liver was implicated in the improvement of glucose
disposal by curcumin, we conducted intraperitoneal pyruvate
tolerance tests (IPPTT) at the end of the 23
week. As shown in
Fig. 2B, glucose production following pyruvate administration was
significantly enhanced in the HFD fed mice, while curcumin
significantly blocked the effect of HFD, indicating that increased
hepatic gluconeogenesis by HFD feeding was inhibited by dietary
curcumin. Finally, we conducted intraperitoneal insulin tolerance
tests (IPITT) at the end of 26 weeks. Insulin was less effective in
lowing glucose level in HFD animals, while curcumin supplemen-
tation efficiently blocked this effect of HFD. These data suggest
that curcumin improves whole body glucose disposal by both
stimulation of insulin sensitivity and inhibition of hepatic
Curcumin improved insulin signaling in adipose tissue
and hepatocytes
To further explore molecular mechanisms underlying the
protective effects of dietary curcumin, we assessed insulin signaling
by determining PKB/Akt Ser473 phosphorylation in response to
insulin injection in insulin responsive tissues. We did not see the
deleterious effect of our HFD on insulin stimulated PKB Ser473
phosphorylation in soleus and gastrocnemius muscles (Figure S1).
However, in both adipose tissue and liver, HFD impaired insulin-
stimulated PKB phosphorylation and the impairment was
prevented by curcumin supplementation (Fig. 3A and 3B).
Fig. 3C shows that in the human hepatic cell line HepG2, insulin
stimulated PKB Ser473 phosphorylation (lanes 1 and 2), while
glucose oxidase (GO) pre-treatment, which is known to induce
oxidative stress [25], blocked the stimulatory effect of insulin (lane
3). Curcumin, however, was found to dose-dependently restore the
stimulatory effect of insulin, in the presence of GO (lanes 4–8).
Curcumin did not stimulate Wnt signaling in mature
We have observed previously that insulin stimulates b-cat
Ser675 phosphorylation in a gut endocrine L cell line (data not
shown) and non-endocrine intestinal cells [22], which represents a
novel mechanism for the crosstalk between insulin (possibly other
signaling molecules) and the Wnt signaling pathway [26,27]. Here
we tested whether this crosstalk occurs in mature adipocytes. After
the mice received intraperitoneal insulin injection for 30 min, we
took the epididymal fat tissue for Western blotting. As shown in
Fig. 4A, in adipose tissue, there was no stimulation on b-cat
Ser675 phosphorylation in any of the three groups of animals,
although stimulation of GSK3a/bphosphorylation was apprecia-
ble. Furthermore, curcumin reduced the overall levels of both
Ser675 b-cat and total b-cat (Fig. 4A). In addition, HFD increased
total GSK-3blevel, while curcumin reduced the level of total
GSK-3b. Finally, curcumin supplementation showed no stimula-
tion on the expression of c-Myc and cyclin D1 protein, two
downstream targets of the Wnt signaling pathway (Fig. 4A) [28].
Real time RT-PCR also showed that dietary curcumin did not
stimulate the expression of cyclin D1 and LRP5 mRNA (data not
Table 1. List of oligonucleotide primers utilized in this study.
Genbank#DNA Sequence
Anticipated size of the
product (bp)
ChREBP NM_021455.3 Forward:59-ACCGGGGTGCCCATCACACA-39315
SREBP-1c NM_011480.2 Forward:59-TAGAGCATATCCCCCAGGTG-39244
L-PK NM_013631.1 Forward:59-GAGTCGGAGGTGGAAATTGT-39173
TxNIP NM_023719.2 Forward:59-AGAGCAGCCTACAGGTGAGA-39260
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 3 January 2012 | Volume 7 | Issue 1 | e28784
shown). Taken together, these observations indicate that in this
animal model, curcumin did not stimulate Wnt pathway
components or Wnt pathway downstream target genes in mature
We then conducted further experiments in primary rat
adipocytes. Fig. 4B shows that treating rat adipocytes with insulin,
or curcumin, or insulin plus curcumin for 5 to 60 min generated
no significant effect on total GSK-3bor Ser675 b-cat expression
level. Total b-cat level, however, appeared to be repressed by
curcumin treatment. Furthermore, curcumin did not block the
stimulatory effect of insulin on GSK-3 phosphorylation. Within
60 min, curcumin or insulin had no observable effect on the
expression of c-Myc or cyclin D1. We then extended the treatment
time by curcumin to 4 h. As shown in Fig. 4C, curcumin
moderately repressed the expression cyclin D1 and greatly
repressed the expression of c-Myc, associated with no appreciable
effect on GSK-3 phosphorylation. Taken together, we did not see
a stimulation of curcumin on Wnt pathway components or Wnt
target gene expression in vivo in the cultured mature adipocytes.
Curcumin attenuated the inflammatory and oxidative
pathway in adipocytes
In mature adipocytes, increased oxidative stress in response to
HFD could contribute to increased inflammatory signaling, which
is at least partially responsible for the impairment of whole body
insulin sensitivity [29]. Curcumin was found to attenuate oxidative
Figure 1. Long term dietary curcumin supplementation prevents HFD-induced obesity and fat mass. (A) Comparison of the body
weight change of mice fed with LFD, HFD or HFD plus curcumin for 28 weeks (n = 4 for LFD or HFD, and n = 8 for HFD/curcumin). a, LFD versus HFD;
b, HFD versus HFD/curcumin. *, p,0.05. (B) Weights of the epididymal fat pad (n = 4 for LFD and HFD, n = 8 for HFD/curcumin). **, p,0.01. (C) Total
body fat volume assessed by MRI at 26 weeks (n =4 for all three groups).
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 4 January 2012 | Volume 7 | Issue 1 | e28784
Figure 2. Curcumin supplementation improves glucose disposal and insulin sensitivity. Assessment of glucose metabolism in animals
with LFD, HFD or HFD plus curcumin feeding. (A) IPGTT (n = 4, 20 weeks), (B) IPPTT (n = 4, 23 weeks), and (C) IPITT (n = 4, 26 weeks). AUC, area under
the curve. *, p,0.05; **, p,0.01.
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 5 January 2012 | Volume 7 | Issue 1 | e28784
stress and reduce the inflammatory response [7]. We observed that
HFD reduced the ratio of GSH/GSSG (1.2360.27 for LFD,
compared with 0.960.17 for HFD), but the difference did not
reach statistical significance. Curcumin supplementation, however,
significantly increased GSH/GSSG ratio (1.3960.24), when
compared with the HFD group (p,0.01). In addition, we found
that in rat primary adipocytes, 20 mM curcumin significantly
increased the expression of HO-1, a fundamentally important
enzyme of the endogenous anti-oxidant system (Fig. 5A). Curcu-
min treatment, however, did not generate a substantial effect on
NF kB or pJNK levels (Fig. 5A), possibly due to the absence of an
oxidative stress in this in vitro assay. Furthermore, dietary
curcumin not only attenuated the stimulatory effect of HFD on
the size of adipocytes, but also completely blocked the effect of
HFD on macrophage infiltration, determined by the expression of
F4/80 in epididymal adipocytes (Fig. 5B). Finally, in mice,
curcumin attenuated the stimulation of HFD on the inflammatory
response, indicated by the inhibition of the rise in NF-kB
expression level (both in whole cell lysates and nuclear extract)
and JNK signaling pathway activation (Fig. 5C). These observa-
tions are generally consistent with previous findings by other
groups [12,30], and collectively suggest that the inhibition of
oxidative stress and the inflammatory pathway in adipose tissue
are among the mechanisms underlying the protective effect of
Figure 3. Curcumin improves insulin stimulated PKB phosphorylation in fat tissue and hepatocytes. (A) and (B) The three groups of
mice fed with the diets as indicated for 28 weeks were fasted overnight and injected with PBS or insulin. After 30 min, the mice were sacrificed.
Samples of epididymal fat pad (A) and liver (B) were prepared and immunoblotted with PKB or Ser473 phosphorylated PKB (p-PKB) antibody. (C)
HepG2 cells were pre-treated with or without curcumin at indicated concentration overnight, followed by a 6 h treatment with or without glucose
oxidase (GO). The cells were then further treated with or without insulin (100 nM) for 10 min, followed by PKB and p-PKB immunoblotting. The blots
shown are representative of 3 separated experiments.
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 6 January 2012 | Volume 7 | Issue 1 | e28784
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 7 January 2012 | Volume 7 | Issue 1 | e28784
dietary curcumin in improving insulin signaling, attenuating
obesity, and preventing the development of diabetes.
Curcumin reduced hepatic lipogenic gene expression
We have then examined histological changes in the liver of each
group of the mice. As shown in Fig. 6, HFD consumption increased
liver lipid content, demonstrated by both H&E staining (Fig. 6A)
and Oil Red O staining (Fig. 6B). In the curcumin group, however,
the effect of HFD on the elevation of lipid content was blocked. The
effect of HFD on macrophage infiltration (assessed by F4/80
staining) was also blocked by curcumin consumption (Fig. 6C).
In this chronic HFD mouse model, although liver weight was
not significantly increased (Fig. 7A), intra-hepatic lipid content
(assessed by MRI) was increased more than 6 fold (Fig. 7B),
consistent with the observation by H&E and Oil Red O staining.
Curcumin significantly reduced liver weight (Fig. 7A) and blocked
the effect of HFD on increasing intra-hepatic lipid content
(Fig. 7B). Furthermore, curcumin reduced hepatic NF-kB level,
although our HFD did not cause the increase of hepatic NF-kB
level (Figure S2).
ChREBP and SREBP1-c are two well known transcription
factors which stimulate lipogenic gene expression, while L-PK is a
downstream target of ChREBP [31]. We found that in this HFD
mouse model, hepatic ChREBP protein level but not SREBP-1c
protein level, was increased (Fig. 7C). However, dietary curcumin
reduced the levels of these two transcription factors (Fig. 7C). At
mRNA level, dietary curcumin significantly reduced the amounts
of SREBP-1c, ChREBP and L-PK (Fig. 7D). The mRNA level of
Stearoyl-coenzyme A desaturase 1 (SCD1) in our HFD mice,
however, was not increased. Curcumin treatment did not generate
a significant change on its expression (Figure S3).
TxNIP is a sensor of glucose and oxidative phosphorylation
status [32]. A recent study indicated that TxNIP transcription can
be stimulated by ChREBP [33]. We found that TxNIP protein
level in the liver was higher in the animals of the HFD group,
while curcumin supplementation reduced its level (Fig. 7C).
Curcumin supplementation also reduced TxNIP mRNA level
(Fig. 7D). Furthermore, we conducted LUC reporter analysis,
showing that in the HepG2 cell line, ChREBP promoter activity
was repressed by curcumin treatment (Fig. 7E). Finally, we found
that HFD feeding increased the phosphorylation of S6K1, a
downstream target of mTOR signaling (Fig. 7F).
Curcumin is the principal curcuminoid of the popular spice
turmeric utilized in Indian and other South Asia countries, which
is a member of the ginger family. This plant polyphenolic
compound has anti-tumor, anti-proliferative, anti-oxidant, and
anti-inflammatory properties [7]. Since the last decade, a few
clinical trials have been conducted, showing the therapeutic effects
of curcumin on various cancers and Alzheimer’s disease [34].
In C57BL/6J HFD fed mice, oral curcumin supplementation
was shown to prevent the development of obesity-associated
inflammation, insulin resistance, as well as diabetes [12]. The
beneficial effect of curcumin in that study was mainly attributed to
the reduction of macrophage infiltration of the adipose tissue, the
increase of adiponectin production, as well as the decrease of
hepatic NF-kB activity [7,12]. The anti-adipogenic effect of
curcumin was then demonstrated in the 3T3-L1 cell model by
other groups [35,36]. The stimulation of HFD on hepatic NF-kB
level, however, was not observed in the current study with our
chronic HFD model, although curcumin supplementation de-
creased NF-kB level in the liver (Figure S2).
Insulin resistance and obesity in C57BL/6J mice are often
induced in the short-term by feeding a diet containing saturated
fatty acids (45%) or with a mixed fatty acid diet with 60% energy
from fat. In the current study we utilized a chronic HFD feeding
model, in which mice did not develop obesity before 16 weeks, and
the deleterious effect of HFD on both the morphology of the liver
and plasma metabolic profiles were not as severe as the utilization
of regular HFD [8] (data not shown). As presented, although our
HFD reduced plasma adiponectin level, it did not reach statistical
significance. Nevertheless, curcumin consumption generated a
significant increase of plasma adiponectin. Furthermore, instead of
routinely providing curcumin-containing HFD with every meal
[12], we provided the curcumin-supplemented diet only two days
per week. This model may more closely mimic the natural
development of insulin resistance, associated with modest dietary
changes along with intermittent curcumin consumption in human
subjects that we can expect. We show in this model that curcumin
supplementation blocked the effect of HFD on fat gain, improved
insulin sensitivity and glucose disposal, and reduced intra-hepatic
lipid content. In addition to the confirmation of the effect of
curcumin in stimulating anti-oxidative signaling and attenuating
inflammatory signaling in hepatocytes, we found that curcumin
reduces mRNA levels of ChREBP and SREBP1-c, two key
transcription factors for hepatic lipogenesis, as well as L-PK, an
important downstream target of ChREBP [31,37]. However, we
did not observe that in mature adipocytes curcumin stimulates
Wnt signaling components or Wnt target genes. We therefore
suggest that curcumin exerts its beneficial effect in our HFD fed
mouse model via attenuating oxidative stress and inflammatory
response in the adipose tissue, and reducing lipogenesis in the liver,
without the stimulation Wnt activity in mature adipocytes.
It should be noted that the activation of Wnt signaling is strongly
associated with the development and progression of colon cancer
and other tumors. The chemotherapeutic effect of curcumin has
been partially attributed to the repression of Wnt activity [38]. For
example, in the LNCaP prostate cancer cells, curcumin represses
total b-cat level, as well as GSK-3 phosphorylation, associated with
reduced c-Myc and cyclin D1 expression [38]. In addition, a recent
study indicated that curcumin disrupts the mammalian target of
rapamycine complex (mTOR) [39]. mTOR is not only a
downstream target of insulin signaling, but also serves as an effector
of the Wnt signaling pathway [27,40]. Thus, the repressive effect of
curcumin on mTOR further supports the notion that curcumin
might repress Wnt activity in cancer cells. In the current study, we
show that HFD induced hepatic expression of phosphorylated
S6K1, a downstream target of mTOR. Curcumin consumption
suppressed S6K1 phosphorylation.
The importance of Wnt signaling pathway in metabolic
homeostasis has been broadly recognized recently [41]. Wnt10b
is abundantly expressed in mesenchymal precursor cells. Wnt10b
Figure 4. Curcumin does not stimulate the Wnt signaling pathway in mature adipocytes. (A) Samples from epididymal fat pad of the
three groups of mice were prepared for Western blotting. b-cat and GSK-3 represent Wnt pathway effectors, while cyclin D1 and c-Myc are two
known Wnt target genes. (B) Rat primary adipocytes were prepared and treated with insulin (100 nM), or curcumin (20 mM), or insulin plus curcumin
for 0, 5, 30, and 60 min. Samples were collected for Western blotting, with indicated antibody. (C) Rat primary adipocytes were prepared and treated
with 10 or 20 mM curcumin for 4 h, followed by Western blotting with indicated antibody. All panels show the representative blot (n = 3).
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 8 January 2012 | Volume 7 | Issue 1 | e28784
mediated Wnt activation stimulates the expression of osetogenic
genes at the expense of adipogenic genes [18]. Furthermore,
ectopic expression of Wnt10b in transgenic mice impairs the
development of the adipose tissue and these mice are resistant to
HFD induced obesity [42,43]. Very recently, a study demonstrat-
ed that in the 3T3-L1 cell model, the repression of adipogenic
differentiation was accompanied by Wnt/b-cat activation [19].
The authors found that during adipocyte differentiation, curcumin
reduced the expression of the components of the destructive
complex that are responsible for b-cat degradation, including
Figure 5. Curcumin increases HO-1 expression and reduces inflammatory markers in mature adipocytes. (A) Rat primary adipocytes
were prepared and treated with 10 or 20 mM curcumin for 4 h. Western blotting was performed with the indicated antibodies. (B) Immunostaining
was performed for the detection of macrophage infiltration marker F4/80 in the fat tissue of the three groups of mice. Arrows show the positive
staining. No macrophage infiltration was observed in LFD or HFD/Curcumin animals. (C) Samples from epididymal fat pad of the three groups of mice
were prepared for Western blotting. WSL, whole cell lysates; Nuclear, nuclear extracts. Panel A and C show representative blots (n = 3).
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 9 January 2012 | Volume 7 | Issue 1 | e28784
CK1a, GSK-3band Axin, accompanied by increased expression
of total b-cat, Wnt10b, the Wnt pathway receptor Fz2, the co-
receptor LRP5, as well as the Wnt targets c-Myc and cyclin D1
[19]. This study provides a potential novel molecular mechanism
to explain the repressive effect of curcumin on adipogenesis. In
contrast, we found in the current study that the stimulatory effect
of curcumin on Wnt signaling does not occur in mature
adipocytes. How this plant dietary compound exerts opposite
Figure 6. Histological assessment of mouse liver. Representative histological slides show lipid content (A, H&E staining; B, Oil Red O staining)
and macrophage infiltration (C) in the three groups of mice.
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 10 January 2012 | Volume 7 | Issue 1 | e28784
effects on Wnt signaling pathway in pre-adipocytes versus mature
adipocytes deserves further investigations. Nevertheless, we have
previously noted cell-type specific effects of Wnt and/or insulin
signaling. For example, both insulin and lithium chloride, the
latter mimics Wnt activation, stimulate proglucagon gene (gcg)
transcription in gut endocrine L cells, but repress the same gcg
gene in pancreatic islets [44,45,46]. Furthermore, we found the
stimulatory effect of insulin on b-cat Ser675 phosphorylation in
the gut [22], but not in adipocytes (this study). Finally, one study
has shown that in skeletal muscle cells, Wnt activation increases
insulin sensitivity through reciprocal regulation of Wnt10b and
SREBP-1c [47], while another group showed that Wnt activation
in mature adipocytes leads to adipocyte dedifferentiation and
insulin resistance [20].
In this study, curcumin blocked the effect of HFD on
macrophage infiltration in adipose tissue, associated with the
Figure 7. Curcumin reduces intra-hepatic lipid content and lipogenic gene expression. (A) Curcumin supplementation reduced liver
weight in HFD fed mice (n = 4 for all 3 groups). (B) MRI shows that curcumin supplementation reduced intra-hepatic lipid content (n = 4 for all 3
groups). (C) Curcumin supplementation reduced the expression of TxNIP, ChREBP and SREBP-1c in liver of HFD fed mice (A representative blot, n = 3).
(D) Curcumin supplementation reduced liver ChREBP, SREBP-1c, L-PK and TxNIP mRNA expression in HFD fed mice (n = 3). (E) The ChREBP-LUC
reporter plasmid construct (3 mg) were transfected into HepG2 cells for 24 h, followed by a 20 h serum starvation and a 4 h curcumin (20 mM)
treatment. The data are presented as mean 6SEM (n = 3). *; p,0.05; **, p,0.01. F. Curcumin supplementation blocked the stimulatory effect of HFD
on S6K1 phosphorylation in the liver.
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 11 January 2012 | Volume 7 | Issue 1 | e28784
repression of NF-kB level and JNK activity, the improvement of
insulin stimulated PKB phosphorylation in adipose tissue and
liver, as well as glucose disposal. These observations are consistent
with current concepts that the activation of endogenous anti-
oxidative system and the repression of inflammatory signaling in
adipocytes improve insulin resistance [48]. Whether there are
additional mechanisms underlying the improvement of insulin
signaling by curcumin supplementation deserves further investi-
gations. For example, mTOR is involved in the development of
insulin resistance via a negative feedback loop, i.e. the inhibition of
IRS-1 tyrosine phosphorylation [49], while the inhibitory effect of
curcumin on mTOR has been demonstrated in certain cancer
cells [39,50]. Since Wnt activation in adipocytes may lead to
insulin resistance [20], the inhibition of mTOR by curcumin may
result in increased insulin sensitization, because mTOR is also
among the effectors of the Wnt signaling pathway [27,40],
Accelerated hepatic lipogenesis is commonly observed in a
number of metabolic disorders, including insulin resistance,
metabolic syndrome and T2D [51]. The increase in lipogenesis
is another mechanism by which HFD consumption leads to
obesity and diabetes. ChREBP and SREBP-1c are two key
transcription factors for genes that encode lipogenic enzymes
[31,37]. Very little is known about the effect of curcumin on
hepatic lipogenesis, although a recent study showed that in
adipocytes curcumin inhibits fatty acid synthase (FAS) [52]. We
found that curcumin reduced liver weight and intra-hepatic lipid
content. More importantly, dietary curcumin was shown to repress
SREBP-1c and ChREBP expression. This, along with the
repression of L-PK by curcumin and the in vitro ChREBP LUC
reporter analysis, suggest that inhibition of ChREBP expression
and function are among the mechanisms by which this dietary
component prevents obesity and its associated metabolic defects. It
should also be pointed out that curcumin can block cardiac
hypertrophy and the implicated underlying mechanism was the
repression of p300-HAT activity and hence the inhibition of p300
acetylation of certain transcription factors [13]. ChREBP was
found to require p300 or CBP as a co-factor in stimulating the
expression of TxNIP [33]. We found here that TxNIP protein and
mRNA expression in curcumin fed mice was also reduced. It
remains to be determined whether p300 inhibition is among the
mechanisms by which curcumin reduces the expression of L-PK
and other targets of ChREBP.
Together, our observations confirm that curcumin improves
insulin signaling, glucose disposal, and blocks obesity during HFD
consumption. Our data confirm that in this chronic HFD feeding
model, the function of curcumin is mediated via increasing the
capability of the animals in anti-oxidative stress and attenuating
inflammatory response in adipocytes. Furthermore, in mature
adipocytes, this appears occur independent of Wnt activation as
curcumin did not activate Wnt pathway components or Wnt
downstream target genes. Finally, we revealed the repressive effect
of curcumin on hepatic lipogeneis, associated with the inhibition of
ChREBP and SREBP-1c expression. Further investigation is
required to determine whether the repressive property of
curcumin on p300/CBP is additionally involved in reducing
hepatic lipogenesis. Thus, the development of curcumin as a
therapy for obesity, insulin resistance and T2D is supported.
Supporting Information
Figure S1 No detectable defect by HFD and no appre-
ciable improvement by curcumin on insulin stimulated
PKA Ser473 phosphorylation in muscles- The three groups
of mice fed with indicated diet for 28 weeks were fasted over night
and injected with PBS or insulin. After 30 min, samples of soleus
(A) and gastrocnemius (B) were prepared and immunoblotted with
PKB or Ser473 phosphorylated PKB (p-PKB) antibody.
Figure S2 Curcumin moderately reduced hepatic NF-kB
activity in HFD fed mice although our HFD did not cause
an appreciable elevation of NF-kB activity- Samples from
liver of the three groups of mice were prepared for Western
blotting with indicated antibody.
Figure S3 No significance difference was observed on
hepatic SCD-1 expression in our animal model. RT-PCR
were conducted with the following SCD-1 primes.
GCACCCAGGGAAACCAGGA-39. N = 3 for each group.
The authors would like to thank Mr. Qiang Xu for providing assistance in
histological studies.
Author Contributions
Analyzed the data: WS ZY YC YY TC WF. Directed and planned
research: IGF TJ. Generated data, discussion and manuscript writing: WS
ZY TC. Provided research data: YC YY WF. Did rat mature adipocytes
preparation: HL. Contributed to manuscript writing: WS ZY IGF TJ.
1. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of
obesity. Gastroenterology 132: 2087–2102.
2. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444: 860–867.
3. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al. (2004)
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin
Invest 114: 1752–1761.
4. Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, et al. (2009)
Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad
Sci U S A 106: 17787–17792.
5. Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, et al. (2006) Liver-
specific inhibition of ChREBP improves hepatic steatosis and insulin resistance
in ob/ob mice. Diabetes 55: 2159–2170.
6. Xu F, Gao Z, Zhang J, Rivera CA, Yin J, et al. (2010) Lack of SIRT1
(Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a
role of lipid mobilization and inflammation. Endocrinology 151: 2504–2514.
7. Alappat L, Awad AB (2010) Curcumin and obesity: evidence and mechanisms.
Nutr Rev 68: 729–738.
8. Yu Z, Shao W, Chiang Y, Foltz W, Zhang Z, et al. (2010) Oltipraz upregulates
the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and
prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J
mice. Diabetologia.
9. Bereswill S, Munoz M, Fischer A, Plickert R, Haag LM, et al. (2010) Anti-
inflammatory effects of resveratrol, curcumin and simvastatin in acute small
intestinal inflammation. PLoS One 5: e15099.
10. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, et al. (2002)
Curcumin-induced suppression of cell proliferation correlates with down-
regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein
phosphorylation. Oncogene 21: 8852–8861.
11. Jaiswal AS, Marlow BP, Gupta N, Narayan S (2002) Beta-catenin-mediated
transactivation and cell-cell adhesion pathways are important in curcumin
(diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells.
Oncogene 21: 8414–8427.
12. Weisberg SP, Leibel R, Tortoriello DV (2008) Dietary curcumin significantly
improves obesity-associated inflammation and diabetes in mouse models of
diabesity. Endocrinology 149: 3549–3558.
13. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, et al. (2008) The
dietary compound curcumin inhibits p300 histone acetyltransferase activity and
prevents heart failure in rats. J Clin Invest 118: 868–878.
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 12 January 2012 | Volume 7 | Issue 1 | e28784
14. Barnes PJ (2009) Role of HDAC2 in the pathophysiology of COPD. Annu Rev
Physiol 71: 451–464.
15. Jin T (2008) The WNT signalling pathway and diabetes mellitus. Diabetologia
51: 1771–1780.
16. Manolagas SC, Almeida M (2007) Gone with the Wnts: beta-catenin, T-cell
factor, forkhead box O, and oxidative stress in age-dependent diseases of bone,
lipid, and glucose metabolism. Mol Endocrinol 21: 2605–2614.
17. Schinner S (2009) Wnt-signalling and the metabolic syndrome. Horm Metab
Res 41: 159–163.
18. Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by
Wnt signaling. J Clin Invest 116: 1202–1209.
19. Ahn J, Lee H, Kim S, Ha T (2010) Curcumin-induced suppression of adipogenic
differentiation is accompanied by activation of Wnt/beta-catenin signaling.
Am J Physiol Cell Physiol 298: C1510–1516.
20. Gustafson B, Smith U (2010) Activation of canonical wingless-type MMTV
integration site family (Wnt) signaling in mature adipocytes increases beta-
catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol
Chem 285: 14031–14041.
21. Oakes ND, Thalen PG, Jacinto SM, Ljung B (2001) Thiazolidinediones increase
plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated
control of systemic FFA availability. Diabetes 50: 1158–1165.
22. Sun J, Khalid S, Rozakis-Adcock M, Fantus IG, Jin T (2009) P-21-activated
protein kinase-1 functions as a linker between insulin and Wnt signaling
pathways in the intestine. Oncogene 28: 3132–3144.
23. Sirek AS, Liu L, Naples M, Adeli K, Ng DS, et al. (2009) Insulin stimulates the
expression of carbohydrate response element binding protein (ChREBP) by
attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodo-
main protein octamer transcription factor-1. Endocrinology 150: 3483–3492.
24. Jin T, Drucker DJ (1996) Activation of proglucagon gene transcription through a
novel promoter element by the caudal-related homeodomain protein cdx-2/3.
Mol Cell Biol 16: 19–28.
25. Tirosh A, Potashnik R, Bashan N, Rudich A (1999) Oxidative stress disrupts
insulin-induced cellular redistributio n of insulin receptor su bstrate-1 and
phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular
mechanism for impaired protein kinase B activation and GLUT4 translocation.
J Biol Chem 274: 10595–10602.
26. Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO (2006) Phosphorylation of
beta-catenin by cyclic AMP-dependent protein kinase. J Biol Chem 281:
27. Jin T, George Fantus I, Sun J (2008) Wnt and beyond Wnt: multiple
mechanisms control the transcriptional property of beta-catenin. Cell Signal 20:
28. Sun J, Jin T (2008) Both Wnt and mTOR signaling pathways are involved in
insulin-stimulated proto-oncogene expression in intestinal cells. Cell Signal 20:
29. Monteiro R, Azevedo I (2010) Chronic inflammation in obesity and the
metabolic syndrome. Mediators Inflamm 2010.
30. Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, et al. (2005)
Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an
increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food
Chem 53: 959–963.
31. Uyeda K, Repa JJ (2006) Carbohydrate response element binding protein,
ChREBP, a transcription factor coupling hepatic glucose utilization and lipid
synthesis. Cell Metab 4: 107–110.
32. Yu FX, Chai TF, He H, Hagen T, Luo Y (2010) Thioredoxin-interacting
protein (Txnip) gene expression: sensing oxidative phosphorylation status and
glycolytic rate. J Biol Chem 285: 25822–25830.
33. Cha-Molstad H, Saxena G, Chen J, Shalev A (2009) Glucose-stimulated
expression of Txnip is mediated by carbohydrate response element-binding
protein, p300, and histone H4 acetylation in pancreatic beta cells. J Biol Chem
284: 16898–16905.
34. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: from
ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631–1652.
35. Ejaz A, Wu D, Kwan P, Meydani M (2009) Curcumin inhibits adipogenesis in
3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139:
36. Lee YK, Lee WS, Hwang JT, Kwon DY, Surh YJ, et al. (2009) Curcumin exerts
antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1
adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer
cells. J Agric Food Chem 57: 305–310.
37. Postic C, Dentin R, Denechaud PD, Girard J (2007) ChREBP, a transcriptional
regulator of glucose and lipid metabolism. Annu Rev Nutr 27: 179–192.
38. Choi HY, Lim JE, Hong JH (2010) Curcumin interrupts the interaction between
the androgen receptor and Wnt/beta-catenin signaling pathway in LNCaP
prostate cancer cells. Prostate Cancer Prostatic Dis 13: 343–349.
39. Beevers CS, Chen L, Liu L, Luo Y, Webster NJ, et al. (2009) Curcumin disrupts
the Mammalian target of rapamycin-raptor complex. Cancer Res 69:
40. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, et al. (2006) TSC2 integrates
Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3
to regulate cell growth. Cell 126: 955–968.
41. Jin T, Liu L (2008) The Wnt signaling pathway effector TCF7L2 and type 2
diabetes mellitus. Mol Endocrinol 22: 2383–2392.
42. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, et al. (2004) Wnt10b
inhibits development of white and brown adipose tissues. J Biol Chem 279:
43. Huang X, Charbeneau RA, Fu Y, Kaur K, Gerin I, et al. (2008) Resistance to
diet-induced obesity and improved insulin sensitivity in mice with a regulator of
G protein signaling-insensitive G184S Gnai2 allele. Diabetes 57: 77–85.
44. Yi F, Sun J, Lim GE, Fantus IG, Brubaker PL, et al. (2008) Cross talk between
the insulin and Wnt signaling pathways: evidence from intestinal endocrine L
cells. Endocrinology 149: 2341–2351.
45. Yi F, Brubaker PL, Jin T (2005) TCF-4 mediates cell type-specific regulation of
proglucagon gene expression by beta-catenin and glycogen synthase kinase-
3beta. J Biol Chem 280: 1457–1464.
46. Philippe J (1989) Glucagon gene transcription is negatively regulated by insulin
in a hamster islet cell line. J Clin Invest 84: 672–677.
47. Abiola M, Favier M, Christodoulou-Vafeiadou E, Pichard AL, Martelly I, et al.
(2009) Activation of Wnt/beta-catenin signaling increases insulin sensitivity
through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle
cells. PLoS One 4: e8509.
48. Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal
role in multiple forms of insulin resistance. Nature 440: 944–948.
49. Shah OJ, Wang Z, Hunter T (2004) Inappropriate activation of the TSC/
Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and
cell survival deficiencies. Curr Biol 14: 1650–1656.
50. Rafiee P, Binion DG, Wellner M, Behmaram B, Floer M, et al. (2010)
Modulatory effect of curcumin on survival of irradiated human intestinal
microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B.
Am J Physiol Gastrointest Liver Physiol 298: G865–877.
51. Denechaud PD, Dentin R, Girard J, Postic C (2008) Role of ChREBP in hepatic
steatosis and insulin resistance. FEBS Lett 582: 68–73.
52. Zhao J, Sun XB, Ye F, Tian WX (2011) Suppression of fatty acid synthase,
differentiation and lipid accumulation in adipocytes by curcumin. Mol Cell
Curcumin Prevents Insulin Resistance and Obesity
PLoS ONE | 13 January 2012 | Volume 7 | Issue 1 | e28784

Supplementary resources (3)

... Several other authors have provided additional mechanisms for the CLEE effect on plasma Chol positive effects. Shao et al. (2012) have reported that the polyphenols in CLEE are competitive to the malonylacetyltransferase domain to covalently modify fatty acid synthase, thereby down-regulating the synthesis of triglycerides. Shao et al. (2012) have published that CLEE inhibits hepatic lipogenesis via down-regulation of SREBP-1c and LXR-a expression to turn off the lipogenic genes, suppressing lipogenesis. ...
... Shao et al. (2012) have reported that the polyphenols in CLEE are competitive to the malonylacetyltransferase domain to covalently modify fatty acid synthase, thereby down-regulating the synthesis of triglycerides. Shao et al. (2012) have published that CLEE inhibits hepatic lipogenesis via down-regulation of SREBP-1c and LXR-a expression to turn off the lipogenic genes, suppressing lipogenesis. LXR-a suppression also has been demonstrated to deactivate fatty acid synthase and acetyl-Co-A carboxylase in reducing plasma triglycerides (Shao et al., 2012). ...
... Shao et al. (2012) have published that CLEE inhibits hepatic lipogenesis via down-regulation of SREBP-1c and LXR-a expression to turn off the lipogenic genes, suppressing lipogenesis. LXR-a suppression also has been demonstrated to deactivate fatty acid synthase and acetyl-Co-A carboxylase in reducing plasma triglycerides (Shao et al., 2012). Jang et al. (2008) have also found that CLEE increases plasma HDL in rats by increasing ABCG-1 expression and activating apoA1 and paraoxonase enzyme activity, thus increasing HDL-dependent lipid efflux and plasma HDL levels (Peschel et al., 2007). ...
Full-text available
Introduction: A high fat intake through a high-fat diet (HFD) has been linked to hyperlipidaemia. Hyperlipidaemia is an important risk factor for obesity, metabolic syndrome, atherosclerosis, insulin resistance and hypertension. Curcumin is a yellow pigment obtained from the rhizomes of Curcuma longa, commonly used as a spice and food colourant. Curcumin extract has been published to possess several biochemical benefits, including anti-tumour, anti-inflammatory, antioxidant, anti-carcinogenic and hypo-cholesterolaemic activities. Methods and objectives: This study compared the effect of Meta-Switch (MS) and Curcuma longa ethanolic extract (CLEE) on lipid profiles in Wistar rats fed with HFD. Thirty (30) male Wistar rats were randomly classified into six (6) groups of five (5) rats each. Rats in Group I was fed a normal diet. Rats in Groups (II, III, IV, V and VI) were fed HFD for two (2) weeks. Rats in Group I and II were treated with distilled water. Group III, IV, and V rats were orally administered 1.5, 2.0, and 2.5g/Kg of CLEE for another 2 weeks. Group VI rats were orally administered 1g/Kg of MS supplement for 2 weeks. After 2 weeks, the animals were humanely sacrificed. Blood samples were collected in heparinized bottles to obtain plasma samples for the measurement of total cholesterol (Chol), triglycerides (Trig), high-density lipoprotein-cholesterol (HDL) and low-density lipoprotein-cholesterol (LDL). Results: Group II rats fed with HFD had high plasma Chol, LDL, and Trig but low HDL levels compared to Control Group I and Groups II, III, IV, V and VI (p < 0.05, p < 0.01 or p < 0.001). However, Groups III, IV, V and VI rats administered with CLEE and MS, respectively, after HFD had a reverse of Group II rats with HFD alone, i.e. low plasma Chol, LDL, and Trig but high LDL levels compared to the Group II rats (p < 0.05, p < 0.01 or p < 0.001). The low plasma Chol, Trig and LDL and the high plasma HDL obtained were more in 2.5 g/Kg followed by 2.0 g/Kg and 1.5 g/Kg CLEE. The plasma LDL and HDL were lower and higher, respectively, in Group VI, administered with 1 g/Kg MS than those of Group V, administered with 2.5 g/Kg CLEE after HFD. HFD produced high plasma lipid profile in the Wistar rats. However, CLEE or MS supplements improved the plasma lipid profile after HFD in the rats. Nonetheless, MS produced a better improvement in the plasma lipid profile than CLEE in the rats. Conclusion: MS may be useful in reducing the plasma levels of total Chol, LDL, and Trig and improves the level of HDL in humans.
... • Inhibit NF-κB and JNK signaling pathway Inhibit lipogenic gene expression in liver [63] Obesity-induced inflammation and insulin resistance(skeletal muscles of Mus musculus) ...
... Moreover, quercetin treatment results in the inhibition of TNF-α-induced inflammation and insulin resistance in adipocytes by improving the activity of insulin-stimulated glucose uptake and prevents TNF-α-induced serine phosphorylation of IRS1 and gene expression of protein tyrosine Phosphatase-1B, suggesting the potential of quercetin in ameliorating obesity-induced inflammation and insulin resistance [62]. Similarly, the curcumin therapy attenuates inflammation by inhibiting the NF-κB and JNK signaling pathway and lipogenic gene expression in hepatic tissues of C57BL/6J mice consuming high-fat diet [63]. Another study by Zhao et al. reported that raspberry treatment significantly downregulates TNF-α, IL-1β, IL-6, and phosphorylation of JNK in high-fat-diet mice. ...
... Similarly, curcumin supplementation inhibits hepatic gluconeogenesis and improves the insulin sensitivity by lowering the glucose level and insulin-stimulated PKB phosphorylation in fat tissues and hepatocytes of animals consuming high-fat diet. They also showed that animals receiving high-fat diet cause an increase in the level of GSK-3β, whereas curcumin treatment did not stimulate the Wnt pathway by reducing the overexpression of c-Myc and cyclin D1 protein in adipocytes [63]. ...
Obesity, a metabolic disorder, is becoming a worldwide epidemic that predominantly increases the risk for various diseases including metabolic inflammation, insulin resistance, and cardiovascular diseases. However, the mechanisms that link obesity with other metabolic diseases are not completely understood. In obesity, various inflammatory pathways that cause inflammation in adipose tissue of an obese individual become activated and exacerbate the disease. Obesity-induced low-grade metabolic inflammation perturbates the insulin signaling pathway and leads to insulin resistance. Researchers have identified several pathways that link the impairment of insulin resistance through obesity-induced inflammation like activation of Nuclear factor kappa B (NF-κB), suppressor of cytokine signaling (SOCS) proteins, cJun-N-terminal Kinase (JNK), Wingless-related integration site (Wnt), and Toll-like receptor (TLR) signaling pathways. In this review article, the published studies have been reviewed to identify the potential and influential role of different signaling pathways in the pathogenesis of obesity-induced metabolic inflammation and insulin resistance along with the discussion on potential therapeutic strategies. Therapies targeting these signaling pathways show improvements in metabolic diseases associated with obesity, but require further testing and confirmation through clinical trials.
... Male C57BL/6J mice (n = 12/group) LFD (10% kcal from fat), HFD (45% kcal from fat), and HFD + curcumin (4 g/kg diet) added 2 days/week for 28 weeks ↓ Macrophage infiltration ↓ NF-κB expression and JNK signaling pathway activation in AT Shao et al. [114] Obese individuals (males and females, n = 30) receiving 1g of CUR per day Randomized, double-blind, crossover ↓ IL-1β, ↓ IL-4, and ↓ VEGF ↔ Other proinflammatory cytokine levels (e.g., IL-1, IL-6, TNF-α) ...
... Other authors indicated that CUR significantly decreased body weight/fat gain, glucose disposal, and IR development in HFD mice. In addition, CUR blocks the effects of HFD on macrophage infiltration and the inflammatory and oxidative pathways in AT and attenuates lipogenic gene expression in the liver (Table 1) [114]. ...
Full-text available
Dietary patterns are promising strategies for preventing and treating obesity and its coexisting inflammatory processes. Bioactive food compounds have received considerable attention due to their actions against obesity-induced inflammation, with limited harmful side effects. They are perceived as food ingredients or dietary supplements other than those necessary to meet basic human nutritional needs and are responsible for positive changes in the state of health. These include polyphenols, unsaturated fatty acids, and probiotics. Although the exact mechanisms of bioactive food compounds’ action are still poorly understood, studies have indicated that they involve the modulation of the secretion of proinflammatory cytokines, adipokines, and hormones; regulate gene expression in adipose tissue; and modify the signaling pathways responsible for the inflammatory response. Targeting the consumption and/or supplementation of foods with anti-inflammatory potential may represent a new approach to obesity-induced inflammation treatment. Nevertheless, more studies are needed to evaluate strategies for bioactive food compound intake, especially times and doses. Moreover, worldwide education about the advantages of bioactive food compound consumption is warranted to limit the consequences of unhealthy dietary patterns. This work presents a review and synthesis of recent data on the preventive mechanisms of bioactive food compounds in the context of obesity-induced inflammation.
... In this study, curcumin was found to suppress the expression of LPS-induced proinflammatory cytokines in fully differentiated 3T3-L1 adipocytes. The anti-inflammatory effects of curcumin have been reported in various experimental models and humans [7,[21][22][23][24][25]. In 3T3-L1 murine adipocytes, curcumin suppressed the TNF-α-induced upregulation of Il1b, Il6, and Tnfa mRNA expression [7]. ...
... In 3T3-L1 murine adipocytes, curcumin suppressed the TNF-α-induced upregulation of Il1b, Il6, and Tnfa mRNA expression [7]. In diet-induced or genetically obese mice, curcumin reduced macrophage infiltration in the white adipose tissue and NF-κB activity in the liver [21,22]. In an atherosclerotic mouse model, curcumin administration alleviated atherosclerotic lesions; lowered plasma cholesterol, TAG, and LDL levels; and increased the HDL level [23]. ...
Full-text available
Background/objectives: Curcumin is a well-known phytochemical with anti-inflammatory effects. Heat shock protein (HSP) 70, an intracellular chaperone, inhibits proinflammatory signaling activation. Although curcumin has been shown to induce HSP70 expression in various cell types, whether HSP70 mediates the anti-inflammatory effects of curcumin in mature adipocytes remains unclear. Materials/methods: To assess the role of HSP70 in regulating the anti-inflammatory response to curcumin in adipocytes, fully differentiated 3T3-L1 adipocytes were treated with curcumin, lipopolysaccharide (LPS), and/or the HSP70 inhibitor pifithrin-μ (PFT-μ). The expression levels of HSP70 and proinflammatory cytokines were then measured. Results: Curcumin upregulated HSP70 expression at both protein and mRNA levels and attenuated LPS-induced Il6, Ptx3, and Ccl2 mRNA upregulation. PFT-μ tended to exacerbate the LPS-induced upregulation of Il6, Ptx3, Ccl2, and Tnfa mRNA expression. However, on curcumin pretreatment, the tendency of PFT-μ to upregulate LPS-induced proinflammatory cytokine expression decreased or disappeared. Conclusion: These results indicate that HSP70 is involved in the regulation of inflammatory responses but may not be crucial for the anti-inflammatory effects of curcumin in 3T3-L1 adipocytes.
... In vitro studies ↓ mTORC1 signal in human intestinal epithelium cells [13] ↓ TORC1 signal in human intestinal epithelium cells [13] ↓ mTORC1 signal in human intestinal epithelium cells more efficiently than CUR alone [13] ↑ GLUT4 translocation in skeletal muscle cells, adipocytes and hepatocytes [14,15] ↑ intracellular Ca 2+ level with activation of CaMKKβ and consequent increase of GLUT4 translocation in L6 myotubes [16] ↓ TNFα gene expression [13] ↑ GLUT4 expression and ↓ GLUT1 expression in hypoxic adipocytes [17] ↑ anti-diabetic activity by PPAR-gamma and ↑ insulin-sensibility in 3T3-L1 cells. [18,19] ↑ Akt phosphorylation [20] ↓pro-inflammatory cytokines in skeletal muscle cells, adipocytes and hepatocytes cells [21] ↓ gluconeogenesis and glycogenolysis in hepatocytes cells [22] ↓ G6Pase and PECK activity [22] ↓ mRNA expression of 11 PDE isoenzymes (PDE3B, PDE8A, PDE10A) in pancreatic islets, in dose-dependent [23] ↓ DPP IV in Caco2 cells [24] ↑ GLP-1 secretion via Ca 2+ /calmodulin-dependent Kinase pathway [25] ↑ insulin secretion in pancreatic islets via PDE/cAMP regulation and ↑ recovery of pancreatic islets [23] In vivo animal and human studies ↓ glucose serum and HbA1c levels [26,27] ↑ Ca 2+ level with consequent translocation by APMK phosphorylation in Wistar rats [16] ↑ recovery of intestinal permeability and integrity and ↓ oxidative stress in weaned Wuzhishan piglets [28]↓ ↓ hyperlipidemia and hyperglycemia [29] ↓ body weight, hepatotoxicity and peroxidation in diabetic animal models induced by streptozotocin [18,30] inflammation index levels and ↓ weight in high-fat-diet-RC-induced mice [31] ↓ Inhibition of NLP3 inflammasome activation in genetic diabetes animals [32] ↑ improved lipid profile in high-fat diets induced rats [33] ↓ total cholesterol, LDL with no effect on TG in a patient with metabolic syndrome [34] ↓ serum glucose and leptin, ↑ adiponectin and ↓insulin resistance in diet-induced diabetes models [35,36] ↑ improves insulin signal in HFD-induced hepatic steatosis, ↓plasma adiponectin and glucose levels [33,37] ↓ albumin level and improve glycemic profile in patients with NAFLD [38] ↓ serum glucose, TG, LDL and HbA1c levels in human studies [26] ↓ β-cell-dysfunction in pre-diabetic mice and reduced LPS level [39] ↓ FPI, HOMA index, TG, LDL, hepatic transaminases, γ-GT, cortisol, blood pressure, steatosis index and waist circumference in overweight patients [40] ↓ insulin secretion and HOMA-IR in pre-diabetic and diabetic individuals [41,42] ↓ glucose, HbA1c, C-peptide, alanine and aspartase aminotransferase in T2D patients [12] ↑: increase; ↓: reduction. ...
... In addition, in high-fat diet-induced diabetes models of C57BL/6J mice and albino rats, interventions with curcumin reduced circulating glucose and leptin, with a concomitant increase in adiponectin and overall improvement of insulin resistance [35,36]. ...
Full-text available
The hypoglycemic properties of curcumin supplements in therapeutic doses are well-known and may represent a useful tool for the treatment of chronic diseases such as metabolic syndrome, insulin resistance and type 2 diabetes. The poor bioavailability of curcumin can be improved with the concomitant administration of piperine, with no severe adverse effects on glycemia reported so far in the literature. In this article, we further discuss a previously reported case of a helicopter pilot, affected by grade I obesity who, under curcumin and piperine treatment, experienced a transient loss of consciousness (TLOC), during a low-altitude flight. This episode led to a diagnosis of insulinoma, previously asymptomatic. We hypothesized that the combined effects of curcumin and piperine might have caused a severe hypoglycemic episode and subsequent TLOC. Therefore, further studies should be conducted to evaluate the safety of curcumin and piperine supplementation in subjects with impaired glucose metabolism and insulin secretion.
... In a sample study, dietary supplementation with curcumin up to 80 mg/kg body weight improved insulin sensitivity by reducing fasting plasma glucose in obese rats [91]. Many researchers have shown curcumin to inhibit adipogenesis by blocking the mitotic clonal expansion process, regulating adipocyte energy metabolism [92][93][94]. Also, the Wnt/β-catenin signaling pathway has been reported to participate in curcumin-mediated suppression of adipogenesis in 3T3-L1 cells [95,96], although the mechanism is not yet fully understood. ...
In Asia and Central America, turmeric (Curcuma longa L.), sometimes known as "Indian saffron," is a perennial plant that belongs to the Zingiberaceae family. Due to the dried turmeric rhizomes' high concentration of minerals, proteins, carbs, and lipids, as well as the fact that it is available in a form that is simple to use and contains heat, light, and oxygen. Its excellent storage stability against environmental factors makes it more desirable, particularly in the context of the food business. In this study, based on the research on turmeric, curcumin, and its starch, the molecular mechanisms and pharmacological properties underlying its use in various diseases such as anti-inflammatory, anti-diabetic, antioxidant, anti-obesity, cardio-liver, anti-cancer, anti-arthritis. And its effects on metabolism. In addition to the lack of sufficient studies, it has been argued that its use in the food and pharmaceutical industry is promising when the results of the research are examined.
Full-text available
Introduction In recent decades, the prevalence and incidence of type 2 diabetes mellitus (T2DM) have increased rapidly and represent a significant public health problem worldwide. Long-term T2DM is associated with microvascular complications such as retinopathy, nephropathy, and neuropathy. Prediabetes is a state of hyperglycemia with blood glucose levels higher than normal but lower than the diabetes threshold. Several studies have demonstrated the effectiveness of lifestyle interventions that resulted in a 40% to 70% reduction in diabetes mellitus in adults with prediabetes. These interventions focused on increased physical activity and dietary changes that were able to prevent or delay the onset of T2DM in prediabetes. However, most review studies focused on interventions to prevent T2DM in high-risk groups such as obesity. There was a limitation of reports related to prediabetes. Nevertheless, it remains a high-risk condition for the development of T2DM with a conversion rate of 5% to 10% per year. Therefore, the aim of this study was to review the current evidence on intervention studies aimed at reducing the incidence of type 2 diabetes in prediabetes. Method The researcher conducted a literature search of common online databases such as Medline, Google Scholar, and Cochrane Library between January 2011 and December 2021. Result The intervention for the prevention of T2DM in prediabetes consisted of a lifestyle intervention, a nutritional supplementation intervention, and a pharmacological intervention Conclusion Several studies suggest that T2DM in prediabetes can be prevented by lifestyle modification and pharmacological interventions, or a combined intervention. However, further interventions may be needed to confirm this.
Full-text available
Tüm dünya sorunu olan obezitenin tedavisinde güncel olarak terapötik stratejiler geliştirilmektedir. Memelilerde, işlevleri ve morfolojileri bakımından farklılık gösteren farklı iki tip adipoz doku mevcuttur. Bunlar, embriyogenez sırasında ortaya çıkan kahverengi adipoz doku (KAD); ve doğum sonrası gelişen beyaz adipoz dokudur (BAD). KAD’nun hacmi, enerji harcaması ile pozitif ilişkili olduğu ve obez kişilerde zayıf bireylere göre önemli ölçüde düşük olduğu bilinmektedir. KAD indüksiyonunu ve/veya aktivasyonunu hedefleyen stratejiler, obezite tedavisinde potansiyel olarak faydalı olabileceği düşünülmektedir. Son yıllarda yapılan araştırmalar, KAD aktivasyonu ve BAD kahverengileşmesi ile ilgili mekanizmalar üzerine olan ilgiyi önemli ölçüde artırmaktadır. Bu mekanizmaları amaçlayan kimyasal bileşiklerin yanı sıra çeşitli farmakolojik olmayan bazı müdahale yaklaşımları bulunmaktadır. Bu derlemede, KAD aktivasyonu ve BAD kahverengileşmesi sürecindeki potansiyel terapötik hedefler ve bunları amaçlayan mevcut stratejilere ilişkin kavramlar özetlenmiştir
Full-text available
Turmeric (Curcuma longa) has been used for thousands of years for the prevention and treatment of various chronic diseases. Curcumin is just one of >200 ingredients in turmeric. Almost 7000 scientific papers on turmeric and almost 20,000 on curcumin have been published in PubMed. Scientific reports based on cell culture or animal studies are often not reproducible in humans. Therefore, human clinical trials are the best indicators for the prevention and treatment of a disease using a given agent/drug. Herein, we conducted an extensive literature survey on PubMed and Scopus following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The keywords "turmeric and clinical trials" and "curcumin and clinical trials" were considered for data mining. A total of 148 references were found to be relevant for the key term "turmeric and clinical trials", of which 70 were common in both PubMed and Scopus, 44 were unique to PubMed, and 34 were unique to Scopus. Similarly, for the search term "curcumin and clinical trials", 440 references were found to be relevant, of which 70 were unique to PubMed, 110 were unique to Scopus, and 260 were common to both databases. These studies show that the golden spice has enormous health and medicinal benefits for humans. This Review will extract and summarize the lessons learned about turmeric and curcumin in the prevention and treatment of chronic diseases based on clinical trials.
Full-text available
Curcumin, a polyphenol found in the rhizomes of Curcuma longa, improves obesity-associated inflammation and diabetes in obese mice. Curcumin also suppresses adipocyte differentiation, although the underlying mechanism remains unclear. Here, we used 3T3-L1 cells to investigate the details of the mechanism underlying the anti-adipogenic effects of curcumin. Curcumin inhibited mitogen-activated protein kinase (MAPK) (ERK, JNK, and p38) phosphorylation that was associated with differentiation of 3T3-L1 cells into adipocytes. During differentiation, curcumin also restored nuclear translocation of the integral Wnt signaling component beta-catenin in a dose-dependent manner. In parallel, curcumin reduced differentiation-stimulated expression of CK1alpha, GSK-3beta, and Axin, components of the destruction complex targeting beta-catenin. Accordingly, quantitative PCR analysis revealed that curcumin inhibited the mRNA expression of AP2 (mature adipocyte marker) and increased the mRNA expression of Wnt10b, Fz2 (Wnt direct receptor), and LRP5 (Wnt coreceptor). Curcumin also increased mRNA levels of c-Myc and cyclin D1, well-known Wnt targets. These results suggest that the Wnt signaling pathway participates in curcumin-induced suppression of adipogenesis in 3T3-L1 cells.
Full-text available
Aims/hypothesis: We investigated whether oltipraz, a nuclear respiratory factor 2 alpha subunit (NRF2) activator, improves insulin sensitivity and prevents the development of obesity in mice. Methods: C57BL/6J mice were fed with a low-fat diet (10% of energy as fat), a high-fat diet (HFD) (45% of energy as fat) or a HFD with oltipraz for 28 weeks. The effects of oltipraz on body weight, fat content, glucose disposal, insulin signalling, metabolic profiles and endogenous NRF2 functional status in the three groups of mice were investigated. Results: Oltipraz prevented or significantly attenuated the effect of HFD on glucose disposal, body weight and fat gain. Impairment of protein kinase B/Akt phosphorylation in this HFD-fed mouse model in response to intraperitoneal insulin injection was observed in adipose tissue, but not in the muscles, accompanied by inhibition of AMP-activated protein kinase signalling and activation of p70S6 kinase, as well as reduced GLUT4 content. These defects were attenuated by oltipraz administration. Nuclear content of NRF2 in adipose tissue was reduced by HFD feeding, associated with increased Keap1 mRNA expression and reduced production of haem oxygenase-1 and superoxide dismutase, increased protein oxidation, decreased plasma reduced:oxidised glutathione ratio and the appearance of macrophage marker F4/80. These defects were also restored by oltipraz. Finally, oltipraz attenuated HFD-induced inducible nitric oxide synthase overproduction. Conclusions/interpretation: Impairment of the endogenous redox system is important in the development of obesity and insulin resistance in chronic HFD feeding. NRF2 activation represents a potential novel approach in the treatment and prevention of obesity and diabetes.
Full-text available
The proglucagon gene is expressed in a highly restricted tissue-specific manner in the A cells of the pancreatic islet and the L cells of the small and large intestines. The results of previous experiments indicate that cell-specific expression of the proglucagon gene is mediated by proteins that interact with the proximal G1 promoter element. We show here that the G1 element contains several AT-rich subdomains that bind proteins present in islet and enteroendocrine cell extracts. Electrophoretic mobility shift assay experiments using specific antisera identified the homeobox protein cdx-2/3 (which designates the same homeobox protein called cdx-2 for mice and cdx-3 for hamsters) as a major component of the G1-Gc2 complex in islet and intestinal cells. Mutations of the Gc element that decreased cdx-2/3 binding also resulted in decreased proglucagon promoter activity in islet and intestinal cell lines. The finding that cdx-2/3 mediates activation of the proglucagon promoter in both islet and enteroendocrine cells is consistent with the common endodermal lineage of these tissues and provides new insight into the coordinate regulation of genes expressed in both pancreatic and intestinal endocrine cell types.
Full-text available
The health beneficial effects of Resveratrol, Curcumin and Simvastatin have been demonstrated in various experimental models of inflammation. We investigated the potential anti-inflammatory and immunomodulatory mechanisms of the above mentioned compounds in a murine model of hyper-acute Th1-type ileitis following peroral infection with Toxoplasma gondii. Here we show that after peroral administration of Resveratrol, Curcumin or Simvastatin, mice were protected from ileitis development and survived the acute phase of inflammation whereas all Placebo treated controls died. In particular, Resveratrol treatment resulted in longer-term survival. Resveratrol, Curcumin or Simvastatin treated animals displayed significantly increased numbers of regulatory T cells and augmented intestinal epithelial cell proliferation/regeneration in the ileum mucosa compared to placebo control animals. In contrast, mucosal T lymphocyte and neutrophilic granulocyte numbers in treated mice were reduced. In addition, levels of the anti-inflammatory cytokine IL-10 in ileum, mesenteric lymph nodes and spleen were increased whereas pro-inflammatory cytokine expression (IL-23p19, IFN-γ, TNF-α, IL-6, MCP-1) was found to be significantly lower in the ileum of treated animals as compared to Placebo controls. Furthermore, treated animals displayed not only fewer pro-inflammatory enterobacteria and enterococci but also higher anti-inflammatory lactobacilli and bifidobacteria loads. Most importantly, treatment with all three compounds preserved intestinal barrier functions as indicated by reduced bacterial translocation rates into spleen, liver, kidney and blood. Oral treatment with Resveratrol, Curcumin or Simvastatin ameliorates acute small intestinal inflammation by down-regulating Th1-type immune responses and prevents bacterial translocation by maintaining gut barrier function. These findings provide novel and potential prophylaxis and treatment options of patients with inflammatory bowel diseases.
A gravity traverse made in 1962 along the Richardson Highway between Valdez and Tonsina, Alaska, with a LaCoste and Romberg geodetic meter having a reading sensitivity of 0.01 mgal, was repeated in September 1964 with the same instrument. The observed gravity changes were used in computing elevation changes produced by the March 27, 1964, earthquake. Elevation changes determined by this method are in general agreement with changes determined by post-earthquake releveling of a 1923 Coast and Geodetic Survey first-order geodetic line coincident with the traverse. The conversion factor could not be precisely determined because the maximum elevation change at any station amounted to only about 0.6 meters. Gravity changes observed in other parts of the earthquake area, where greater elevation changes occurred (up to 3 meters), indicate that the conversion factor is closer to the normal Bouguer gravity gradient (0.2 mgal/m) than to a free-air gradient (0.3 mgal/m). This suggests that the elevation changes were accompanied by a net change of the total mass affecting the gravity readings, rather than by purely chemical or elastic changes. The data are preliminary and indicate the need for more pre- and post-earthquake comparisons.
In the United States, obesity among adults and overweight among children and adolescents have increased markedly since 1980. Among adults, obesity is defined as a body mass index of 30 or greater. Among children and adolescents, overweight is defined as a body mass index for age at or above the 95th percentile of a specified reference population. In 2003-2004, 32.9% of adults 20-74 years old were obese and more than 17% of teenagers (age, 12-19 y) were overweight. Obesity varies by age and sex, and by race-ethnic group among adult women. A higher body weight is associated with an increased incidence of a number of conditions, including diabetes mellitus, cardiovascular disease, and nonalcoholic fatty liver disease, and with an increased risk of disability. Obesity is associated with a modestly increased risk of all-cause mortality. However, the net effect of overweight and obesity on morbidity and mortality is difficult to quantify. It is likely that a gene-environment interaction, in which genetically susceptible individuals respond to an environment with increased availability of palatable energy-dense foods and reduced opportunities for energy expenditure, contributes to the current high prevalence of obesity. Evidence suggests that even without reaching an ideal weight, a moderate amount of weight loss can be beneficial in terms of reducing levels of some risk factors, such as blood pressure. Many studies of dietary and behavioral treatments, however, have shown that maintenance of weight loss is difficult. The social and economic costs of obesity and of attempts to prevent or to treat obesity are high
Dysregulations in hepatic lipid synthesis are often associated with obesity and type 2 diabetes, and therefore a perfect understanding of the regulation of this metabolic pathway appears essential to identify potential therapeutic targets. Recently, the transcription factor ChREBP (carbohydrate-responsive element-binding protein) has emerged as a major mediator of glucose action on lipogenic gene expression and as a key determinant of lipid synthesis in vivo. Indeed, liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in obese ob/ob mice. Since ChREBP cellular localization is a determinant of its functional activity, a better knowledge of the mechanisms involved in regulating its nucleo-cytoplasmic shuttling and/or its post-translational activation is crucial in both physiology and physiopathology. Here, we review some of the studies that have begun to elucidate the regulation and function of this key transcription factor in liver.
Curcumin is a well-known component of the cook seasoning and traditional herb turmeric (Curcuma longa), which has been reported to prevent obesity. However, the mechanism still remains to be determined. In this study, curcumin is found to be an effective inhibitor of fatty acid synthase (FAS), and its effects on adipocytes are further evaluated. Curcumin shows both fast-binding and slow-binding inhibitions to FAS. Curcumin inhibits FAS with an IC₅₀ value of 26.8 μM, noncompetitively with respect to NADPH, and partially competitively against both substrates acetyl-CoA and malonyl-CoA. This suggests that the malonyl/acetyl transferase domain of FAS possibly is the main target of curcumin. The time-dependent inactivation shows that curcumin inactivates FAS with two-step irreversible inhibition, a specific reversible binding followed by an irreversible modification by curcumin. Like other classic FAS inhibitors, curcumin prevents the differentiation of 3T3-L1 cells, and thus represses lipid accumulation. In the meantime, curcumin decreases the expression of FAS, down-regulates the mRNA level of PPARγ and CD36 during adipocyte differentiation. Curcumin is reported here as a novel FAS inhibitor, and it suppresses adipocyte differentiation and lipid accumulation, which is associated with its inhibition of FAS. Hence, curcumin is considered to be having potential application in the prevention of obesity.
The incidence of obesity is increasing worldwide and is hence considered a major public health concern. Obesity underlies the development of several metabolic complications including cardiovascular diseases, diabetes, and inflammation. Research on ways to slow the development of obesity have traditionally focused on dietary and lifestyle modifications such as restricting caloric intake and increasing physical activity. An area that has recently aroused considerable research interest is investigating the potential role of spices, particularly the Asian spice turmeric, for combating obesity. Curcumin is the active ingredient in turmeric. Evidence suggests curcumin may regulate lipid metabolism, which plays a central role in the development of obesity and its complications. The present review addresses the evidence and mechanisms by which curcumin may play a role in downregulating obesity and reducing the impact of associated problems.